Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease.
Developing a risk-based composite neurologic outcome for a trial of hydroxyurea in young children with sickle cell disease. Clin Trials. 2019 02; 16(1):20-31.